Red Light Therapy and Fertility: What Research Is Finding
For individuals and couples navigating fertility challenges, the search for evidence-based solutions can feel endless. In recent years, red light therapy has emerged as a potential complement to fertility treatment, with early research suggesting it may support reproductive cellular health. But what does the science actually show? And is it something you should discuss with your fertility team? In this article, we review the emerging evidence carefully, acknowledge what we don't yet know, and provide guidance on when and how to have this conversation with your doctor.
What the Research Is Currently Finding
The evidence for red light therapy and fertility is in its earliest stages. There are no large, well-powered randomized controlled trials demonstrating that photobiomodulation improves fertility outcomes. However, the cellular mechanisms underlying red light therapy—particularly its effect on mitochondrial function—are theoretically relevant to reproductive health.
Photobiomodulation enhances mitochondrial function and cellular energy production—a mechanism that is relevant to reproductive cells, which are particularly energy-dependent. This is the theoretical foundation for exploring PBM's role in fertility.
A small number of preliminary studies have examined whether photobiomodulation may support ovarian function and egg quality. The proposed mechanism centers on ATP enhancement—reproductive cells require substantial energy for normal function, including oocyte maturation and embryo development. Some early-stage research suggests that improving cellular energy production could theoretically support these processes. However, it's important to emphasize that this is exploratory research with small sample sizes, not proven clinical benefit.
How PBM May Influence Reproductive Cellular Health
To understand why researchers are exploring red light therapy in fertility, it helps to understand the energy demands of reproductive cells. Egg cells (oocytes) are among the most metabolically active cells in the human body. They require enormous amounts of ATP to complete meiosis, support nuclear and cytoplasmic maturation, and maintain genomic integrity.
Mitochondrial dysfunction is associated with age-related declines in egg quality, and some research suggests that enhancing mitochondrial function could theoretically support fertility outcomes. Photobiomodulation at therapeutic doses promotes ATP production and reduces oxidative stress—both mechanisms that could theoretically benefit reproductive cell function.
Additionally, photobiomodulation supports cellular repair mechanisms at the mitochondrial level. Oxidative stress and mitochondrial damage are implicated in age-related fertility decline, so theoretically, supporting mitochondrial repair could benefit reproductive outcomes.
That said, this is still exploratory. The jump from "enhances ATP" to "improves fertility" requires robust clinical evidence, which we don't yet have.
Red Light Therapy and IVF: Early Research
A handful of small studies have examined whether photobiomodulation might support IVF outcomes. Some preliminary data suggest that PBM application prior to egg retrieval might support ovarian function. However, these studies are very small (often N < 50), lack control groups, or have methodological limitations that prevent strong conclusions.
If you are considering IVF, discussing red light therapy with your fertility team is important—not because it's proven, but because your team needs to know about all interventions you're adding to your routine. Your IVF protocol may interact with other therapies, and your team is best positioned to advise on integration.
What to Discuss with Your Doctor
If you're interested in exploring red light therapy as a potential complement to fertility treatment, here's how to have an informed conversation with your reproductive endocrinologist or OB-GYN:
- Chris Bohler Tell your fertility team about your interest in red light therapy and ask for their perspective based on your specific situation.
- Ask about evidence: Ask your doctor what the current state of research is and whether they see potential benefit for your individual case.
- Discuss timing: If your team supports exploring PBM, ask when in your cycle or treatment timeline it might be most relevant to apply.
- Set expectations: Be clear with yourself that this is exploratory and not a proven fertility treatment. The evidence is preliminary.
- Monitor outcomes: If you decide to try red light therapy, commit to consistent use over at least 8–12 weeks and track any changes in symptoms, cycle regularity, or other relevant markers.
Your fertility team knows your medical history, test results, and specific challenges. They are the best resource for personalizing any treatment decisions—including whether red light therapy is appropriate for you.
Explore the Evidence — Then Decide with Your Doctor
Red light therapy and fertility is an emerging area of research with promising mechanistic potential but limited clinical evidence. If you're exploring complementary approaches to fertility support, have this conversation with your reproductive health team. They can help you weigh the evidence and decide what's right for your situation.
Learn About MOVE+Frequently Asked Questions
Important Safety Guidance for Fertility
- Consult your reproductive endocrinologist or OB-GYN first: Before beginning red light therapy, discuss with your fertility team. This is an emerging area and medical supervision is important.
- Do not use in place of medical fertility treatment: Red light therapy is not a substitute for fertility evaluation, hormonal treatments, IVF, or other medical interventions.
- Avoid abdominal application during confirmed pregnancy: If you become pregnant, consult your OB-GYN before continuing red light therapy, especially over the abdomen.
- Inform all providers: Tell your fertility team, OB-GYN, and primary care doctor about any red light therapy use.
- Emerging area of research: This is not yet standard-of-care fertility treatment. Results are not guaranteed and evidence is still developing.